Finance

Diagnostics company reports improved second quarter financial results

Published in Biotech Business Week, September 8th, 2003

Boston Biomedica, Inc., (BBII) announced that revenue for the 3 months ended June 30, 2003, was $6,022,987, an increase of $166,891 or 2.8%, compared with revenue of $5,856,096 for the 3 months ended June 30, 2003.

The company incurred an operating loss of $(156,338) in the first quarter of 2003, compared to an operating loss of $(247,487) in the first quarter of 2002. Net loss from operations for the 3 months ended June 30, 2003, declined to $(225,304), or $(0.03) per diluted share, compared with a loss from operations of $(293,893), or $(0.04) per diluted share, for the 3 months ended June 30, 2002.

The operating loss incurred in the second quarter...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2003-09-08)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry